Advances in hydroxamic acid hybrids for liver cancer therapy: a decade of progress (2016-2025).

Liver cancer, which originates from hepatocytes, ranks among the most commonly diagnosed cancers and stands as a leading cause of cancer-related deaths, primarily due to late diagnosis and its rapid progression. Liver cancer, especially metastatic li…

Preview only. Read the full abstract at the source